The HFC announces new collaboration with the AHA Science for the annual HFC Site-Based Research Awards. The 2024 awards will be presented during an event at AHA’s Scientific Sessions in Chicago. Nominations are now open!

To submit nominations, go to: hfcollaboratory.com/nomination/

@HFCollaboratory Spring Think Tank 2024! Always a great opportunity to learn from the best in the business! And so great to see the next class of HFC interns thriving!! #heartfailure #thinktank Christopher O'Connor Mona Fiuzat

Congrats to Dr. Norman Stockbridge on receiving the Lifetime Achievement Award🏆

Dr. Stockbridge has made impressive contributions to the CV research & regulatory arena making a significant impact on the way clinical trials are conducted.
No one is more deserving of this award!

#SimPub in JACC Journals
Does HF trial enrollment contribute to underutilization of therapies among diverse groups in clinical practice?

HFC Intern ISABELLA CAVAGNA presents on Clinical Trial Inclusion manuscript out now at the link below🔗
sciencedirect.com/science/articl…

Anju Bhardwaj MD FACC JACC Journals HF Collaboratory Mona Fiuzat Javed Butler Michael Felker Nikhil Narang, MD Novi Tham Jenny Thibodeau, MD, MSCS Adrian da Silva BiykemBozkurt #HFmrEF doesn’t exist: from a clinical context it adds unneeded confusion, from a research context it is an oversimplification of the continuous spectrum of LVEF.

And another happiest of birthdays to our working group chair Mitchell Psotka

We deeply appreciate all that you do for HFC and wish you nothing but your continued success!

🎉🎉🎉🎉🎉🎉
Mona Fiuzat Christopher O'Connor Anu Lala-Trindade Vanessa Blumer, MD, FACC Joann Lindenfeld Robert Mentz, MD Ankeet S. Bhatt, MD, MBA

Happy Birthday Robert Mentz, MD 🥳

Thank you for being such an integral part of our team! We are wishing you an incredible day and another wonderful year🎉

Mona Fiuzat Christopher O'Connor Mitchell Psotka Anu Lala-Trindade Vanessa Blumer, MD, FACC Michael Felker James Januzzi Jr MD Joann Lindenfeld

Get ready for HFC Special Focus Meeting: Role of #AI in HF #ClinicalTrials

We have a packed agenda, topics ranging from FDA insight on regulatory implications to using AI to predict LVEF

Register Now: hfcollaboratory.com/meetings/regis…

Mona Fiuzat Christopher O'Connor Mitchell Psotka Anu Lala-Trindade Vanessa Blumer, MD, FACC

After an outstanding HF Collaboratory conference, a crucial question remains.....

What does #MitchTheRegulator have to say? Mitchell Psotka

Mona Fiuzat Christopher O'Connor Ankeet S. Bhatt, MD, MBA William Abraham Robert Mentz, MD Anu Lala-Trindade

Read U.S. FDA CDER 2023 report of 55 novel drug therapy approvals.

Having never been approved or marketed in the U.S., they’ll meet many important unmet medical needs for a wide range of conditions and diseases.

fda.gov/drugs/new-drug…

Another reason to stop using plastic and drinking from plastic water bottles. Don’t buy them. Don’t drink from them. Have your Stanley or other such bottles at the ready!
BJCohen, MD - Blue Check Mark🫀Doc Dr Anastasia Mihailidou FAHA FCSANZ FESC Dorian L. Beasley MD, FACC ASPC Michael D. Shapiro Danielle Belardo, MD

apple.news/A1VVBhB9SStmp3…

Standardized definitions for ADHF & endpoint considerations to inform clinical trials, proposed by Anu Lala-Trindade, Christopher O'Connor, et al in @HFCollaboratory/HF-ARC Expert Panel Paper in #JACCHF

Vanessa Blumer, MD, FACC Mitchell Psotka Robert Mentz, MD

jacc.org/doi/10.1016/j.…

How can we best use LVEF in treatment of HF? What is the future of novel HF phenotyping?

Mitchell Psotka and @matt_dimond1 comment on the classification of HF by LVEF, and how the field can move forward. Out NOW in #JACCHF !
JACC Journals

sciencedirect.com/science/articl…

Wishing a happy birthday to Christopher O'Connor 🎂Thank you for all your impactful contributions to the HFC and dedication to the CV community as a whole! Cheers to another year of your success🎈

Mona Fiuzat Mitchell Psotka Maria Rosa Costanzo Vanessa Blumer, MD, FACC Inova Ankeet S. Bhatt, MD, MBA James Januzzi Jr MD Inova Schar Heart and Vascular

HF Collaboratory - HF-ARC labor of love published in JACC Journals (for Christopher O'Connor ‘s birthday 🎂☺️🙌🏽) wherein we propose standardized definitions to streamline trial design/conduct in acute decompensated HF 👇🏽

Dr. Carine Hamo Mona Fiuzat BiykemBozkurt

authors.elsevier.com/a/1iD0J7tD%7EZ…

#CVCT2023 was a success with many HFC members giving insightful talks on cutting edge technology and innovation in CV clinical trials. We already can’t wait for this multi-stakeholder community to come together again CVCT - CardioVascular Clinical Trialists next year

Congratulations James Januzzi Jr MD for being listed as a 2023 Highly Cited Researcher by Clarivate 👏🏻Well deserved recognition for all your hard work and dedication to your research! #HighlyCited2023 #HF #heartfailure

Christopher O'Connor Mona Fiuzat Mitchell Psotka Vanessa Blumer, MD, FACC Nasrien E. Ibrahim MD, MPH Muthu Vaduganathan

Can patient-reported QoL assessments be used as inclusion criteria in HF clinical trials?

Matt Dimond presents at #AHA2023 on advantages ✅ and limitations ❌of using QoL as IE criteria

Read full abstract at ahajournals.org/doi/abs/10.116…

⁉️Did you know phase 3 biotech trials increased 400% in past decade & over HALF of FDA approved novel therapies since 2021 have been biotech products?

⬇️Read below to learn about 📈📈 in late stage biotech research

Mona Fiuzat Christopher O'Connor Mitchell Psotka Vanessa Blumer, MD, FACC
cms.centerwatch.com/articles/26758…

🎉Congratulations to Matt Dimond Mary Looby Palak Shah on their paper on DOAC LVAD Study! Read it now online in Journal of Cardiac Failure

Christopher O'Connor Mona Fiuzat Mitchell Psotka Muthu Vaduganathan Vanessa Blumer, MD, FACC Anu Lala-Trindade Nasrien E. Ibrahim MD, MPH Robert Mentz, MD Ankeet S. Bhatt, MD, MBA